ArticleVeterinary and animal science2026
Supplementation of lupeol during in vitro maturation improves preimplantation embryonic development in pigs.
Article in Veterinary and animal science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Lupeol is a triterpene with several pharmacological properties, including antioxidant activity. This study investigated the antioxidant effects of lupeol supplementation during in vitro maturation (IVM) of porcine oocytes. Oocytes were divided into six groups and matured for 44 h in medium supplemented with lupeol at concentrations of 0, 1, 2, 4, and 8 µM. As a control, oocytes were cultured without lupeol or its dilution solution (dimethyl sulfoxide). After IVM, in vitro fertilization and embryo culture were performed to evaluate fertilization rate and developmental competence. Nuclear maturation, DNA integrity, intracellular glutathione (GSH) levels, reactive oxygen species (ROS) levels, fertilization, embryo development, and embryo quality were assessed. Lupeol at 4 and 8 µM increased metaphase II rates compared with the control group; however, the DNA integrity of the oocyte nucleus did not differ between groups. GSH levels increased, and ROS levels decreased at all concentrations compared with the control group. Monospermic fertilization rate of oocytes matured with 4 µM lupeol was higher than that of the 0 µM and control groups. Among the lupeol concentrations tested in IVM medium, only 4 µM significantly enhanced blastocyst formation. Moreover, 4 µM lupeol reduced DNA fragmentation in blastocysts compared with the 0 and 1 µM groups but did not affect the total cell number of blastocysts. In conclusion, the addition of 4 µM lupeol diluted in DMSO to the culture medium during IVM enhanced blastocyst formation by increasing intracellular GSH and reducing ROS in matured oocytes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.